|Bid||0.0470 x 1692400|
|Ask||0.0835 x 1500000|
|Day's Range||0.0335 - 0.0335|
|52 Week Range||0.0335 - 0.1460|
|Beta (3Y Monthly)||0.37|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we...
TORONTO , June 27, 2019 /CNW/ - Acerus Pharmaceuticals Corporation ("Acerus") (ASP.TO) today announced the voting results from its annual meeting of shareholders held on June 27, 2019 in Toronto, Ontario . The six (6) candidates nominated for election to the Acerus board of directors and listed in Acerus' management information circular dated May 15, 2019 , were elected by a majority of the shareholders present in person or represented by proxy at the meeting. Acerus announced today that its shareholders have approved the re‐appointment of PricewaterhouseCoopers LLP as the Auditor of Acerus to hold office until the next annual meeting of shareholders.
On a per-share basis, the Mississauga, Ontario-based company said it had a loss of 1 cent. The drugmaker posted revenue of $1.6 million in the period. The company's shares closed at 17 cents. A year ago, ...